The Psychedelic News Feed: Feb 5, 2024 – Mar 3, 2024

By

admin

-

March 20, 2024

20

Source

Facebook

X

Previous articlePT496 – Maintenance Doses and Recurring Revenue: The Ethics of At-Home Ketamine Therapy

Next articleNotes from the International Society for Research on Psychedelics’ 2024 Conference in New Orleans (Guest Contribution)

admin

https://psynews.com

Senate Bill S.4031 Signals a Federal Turn Toward Psychedelic Medicine

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

PsyNews.com has a single-sector focus. We are a news platform dedicated to covering the psychedelic industry. This includes companies, startups, venture capital firms, investment banks, pharma, research, etc, anything associated with the new emerging industry and asset class. Many of the chemicals and compounds involved are LSD, psilocybin, DMT, ketamine, MDMA, ecstasy, ibogaine, analogs, derivatives, psychedelic mushrooms, fungi, psilocin, entheogens, empathogens, indocybin, magic truffles (psilocybin sclerotia), etc. They range from classical and standard to new and exotic. PsyNews.com will cover all psychedelic news in the psy industry, including current events, updates, and what’s happening everywhere in the sector in term of developments and investments. We will be tracking companies worth, valuation, ROI, financials, stock, revenue, IPO’s, and more. Along with medical, recreational, clinical trials, FDA, mindfulness, psy space, 5-HT2A receptor experiments, and so forth. Join us on an unforgettable journey to the center of the psychedelic industry.

Facebook Instagram Pinterest Reddit Tumblr X Youtube

©

The Psychedelic News Feed: Feb 5, 2024 – Mar 3, 2024

EDITOR PICKS

ShroomskiCon 2026

Senate Bill S.4031 Signals a Federal Turn Toward Psychedelic Medicine

Psychedelic Culture 2026

POPULAR POSTS

How to Get DMT: Obtaining the Spirit Molecule

Having Sex on DMT: What You Need to Know

DMT Pricing Guide

POPULAR CATEGORY

ShroomskiCon 2026